lenalidomide,tafasitamab
morphosys,incyte
[' lena', 'lenalidomide', 'lymphoma']
how should we treat late (and early) car-t failures? novel targeted drugs and bispecifics, this is not the population for ct or tafa/len as supported by multiple other abstracts. erbella, ash #553. #ash22 
Heme-Onc at the Juravinski Cancer Centre. MD, MPH in Epidemiology. Assistant Professor at McMaster. Runner and outdoor enthusiast!